Skip to search.
 STI Down2.51%

Protalix BioTherapeutics, Inc. (PLX)

-NYSE MKT

5.23 20 Jun 04:03 SGT

Add to Portfolio
Balance SheetGet Balance Sheet for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2012Dec 31, 2011Dec 31, 2010
Assets
Current Assets
Cash And Cash Equivalents52,035  27,001  35,900  
Short Term Investments -   -   -  
Net Receivables1,410  1,374  9,244  
Inventory4,039  279  1,189  
Other Current Assets3,686  3,837   -  
Total Current Assets 61,170   32,491   46,333  
Long Term Investments -   -   -  
Property Plant and Equipment16,310  18,271  17,454  
Goodwill -   -   -  
Intangible Assets -   -   -  
Accumulated Amortisation -   -   -  
Other Assets1,247  1,043  942  
Deferred Long Term Asset Charges -   -   -  
Total Assets 78,727   51,805   64,729  
Liabilities
Current Liabilities
Accounts Payable16,318  12,572  14,340  
Short/Current Long Term Debt -   -   -  
Other Current Liabilities9,437  6,121  4,563  
Total Current Liabilities 25,755   18,693   18,903  
Long Term Debt -   -   -  
Other Liabilities7,441  8,266  1,663  
Deferred Long Term Liability Charges48,888  50,923  55,486  
Minority Interest -   -   -  
Negative Goodwill -   -   -  
Total Liabilities 82,084   77,882   76,052  
Stockholders' Equity
Misc Stocks Options Warrants -   -   -  
Redeemable Preferred Stock -   -   -  
Preferred Stock -   -   -  
Common Stock93  86  81  
Retained Earnings(183,595)(171,977)(135,448)
Treasury Stock -   -   -  
Capital Surplus180,145  145,814  124,044  
Other Stockholder Equity -   -   -  
Total Stockholder Equity (3,357) (26,077) (11,323)
Net Tangible Assets (3,357) (26,077) (11,323)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.